News & Events


Photo of Yichen Zhang

MS student Yichen Zhang parlayed a summer internship with NanoString Technologies into a permanent part-time position.

PHoto of Anna Plantinga

As an undergrad, Anna Plantinga enjoyed math and developed an interest in doing biological research. At UW, she's now working on a variety of methods for studying the human microbiome.


When cancer screenings are challenged for logic

UW Medicine
January 3, 2018
2018 UW Biostatistics Prentice Professor, Ruth Etzioni, PhD, weighs in about ethical medicine and cancer screenings.
Read article »

Washington: Genetic Variants Found to Raise Infection Risk Among HIV-Exposed People

December 7, 2017
A new study published earlier this month in PLOS Pathogens has pinpointed genetic variants that markedly increase HIV infection risk among people exposed to the virus. Mary Emond, co-senior author and primary analyst of the study and research associate professor of biostatistics in the UW Department of Biostatistics is quoted.
Read article »

UW biostatisticians take part in clinical trials of injectable drug to protect against HIV

UW School of Public Health
December 4, 2017
How are UW faculty in biostatistics working to prevent the spread of HIV? This article highlights Thomas Fleming's role in two new large-scale trials of a long-acting injectable drug for HIV prevention, and illuminates the integral role the biostatistician plays on a research team. Other UW faculty members in biostatistics actively involved in leading research for preventing the spread of HIV are also highlighted including: James Hughes, Peter Gilbert, Barbra Richardson and Ying Chen.
Read article »

UW Biostatisticians Studying HIV and Prevention

UW School of Public Health
December 1, 2017
Several faculty members of the School's Department of Biostatistics are actively involved in leading the research for preventing the spread of HIV, including James Hughes, Peter Gilbert and Barbra Richardson.
Read article »

Washington's World AIDS Day Highlights

November 30, 2017
Dr. Thomas Fleming, a UW faculty member in biostatistics, is involved in two large clinical trials engaging more than 6,000 people at high risk for acquiring HIV infection. The trials are aimed at determining whether an injectable medication, given only about every eight weeks, has effectiveness in reducing the risk of HIV infection that is similar or superior to that of a daily antiretroviral pill known as Truvada.
Read article »